Evidence map›Paper›PMID 34095407›Full record

ArticleBladder cancer (Amsterdam, Netherlands)2020

Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions.

Kyle B Zuniga, Rebecca E Graff, David B Feiger, Maxwell V Meng, Sima P Porten, Stacey A Kenfield

Abstract read
In one paragraph

Article in Bladder cancer (Amsterdam, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kyle B ZunigaDepartment of Urology, University of California, San Francisco, CA, USA.
Rebecca E GraffDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
David B FeigerDepartment of Urology, University of California, San Francisco, CA, USA.
Maxwell V MengDepartment of Urology, University of California, San Francisco, CA, USA.
Sima P PortenDepartment of Urology, University of California, San Francisco, CA, USA.
Stacey A KenfieldDepartment of Urology, University of California, San Francisco, CA, USA.

Funding

Training Researchers in Clinical Integrative Medicine (TRIM) - NOSI supplementT32AT003997 · NCCIH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHELLEY R ADLER, MARIA T CHAO · 2007 to 2026
$6.6M
NCCIH NIH HHS T32 AT003997
6 · The paper itself

Abstract

backgroundA broad, comprehensive review of studies exploring associations between lifestyle factors and non-muscle invasive bladder cancer (NMIBC) outcomes is warranted to consolidate recommendations and identify gaps in research.

objectiveTo summarize the literature on associations between lifestyle factors and clinical outcomes among patients with NMIBC.

methodsPubMed was systematically queried for articles published through March 2019 regarding lifestyle factors and recurrence, progression, cancer-specific mortality, and all-cause mortality among patients with NMIBC.

resultsNotwithstanding many ambiguities, there is good-quality evidence suggesting a benefit of smoking avoidance/cessation, healthy body mass index (BMI), and type II diabetes mellitus prevention and treatment.

conclusionsDespite a myriad of publications on lifestyle factors and NMIBC, a need remains for research on unexplored associations (e.g., physical activity) and further studies that can elucidate causal effects. This would inform future implementation strategies for healthy lifestyle change in NMIBC patients.

Indexed as

body mass indexdiabetes mellitusdietdietary supplementslifestylenon-invasiveprognosisrecurrencesmokingUrinary bladder neoplasms

Identifiers

PMID34095407
PMCPMC8174672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.